Evidence map›Paper›PMID 36061801›Full record

ArticleFrontiers in plant science2022

CisCross: A gene list enrichment analysis to predict upstream regulators in

Viktoriya V Lavrekha, Victor G Levitsky, Anton V Tsukanov, Anton G Bogomolov, Dmitry A Grigorovich, Nadya Omelyanchuk, Elena V Ubogoeva, Elena V Zemlyanskaya, Victoria Mironova

Abstract read
In one paragraph

Article in Frontiers in plant science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Viktoriya V LavrekhaDepartment of Systems Biology, Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia.
Victor G LevitskyDepartment of Systems Biology, Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia.
Anton V TsukanovDepartment of Systems Biology, Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia.
Anton G BogomolovDepartment of Cell Biology, Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia.
Dmitry A GrigorovichService of Information Technologies, Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia.
Nadya OmelyanchukDepartment of Systems Biology, Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia.
Elena V UbogoevaDepartment of Systems Biology, Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia.
Elena V ZemlyanskayaDepartment of Systems Biology, Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia.
Victoria MironovaDepartment of Systems Biology, Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Having DNA-binding profiles for a sufficient number of genome-encoded transcription factors (TFs) opens up the perspectives for systematic evaluation of the upstream regulators for the gene lists. Plant Cistrome database, a large collection of TF binding profiles detected using the DAP-seq method, made it possible for Arabidopsis. Here we re-processed raw DAP-seq data with MACS2, the most popular peak caller that leads among other ones according to quality metrics. In the benchmarking study, we confirmed that the improved collection of TF binding profiles supported a more precise gene list enrichment procedure, and resulted in a more relevant ranking of potential upstream regulators. Moreover, we consistently recovered the TF binding profiles that were missing in the previous collection of DAP-seq peak sets. We developed the CisCross web service (https://plamorph.sysbio.ru/ciscross/) that gives more flexibility in the analysis of potential upstream TF regulators for

Indexed as

DAP-seqmulti-omics data integrationproximal promotersRNA-seqtranscription factor binding profiles

Identifiers

PMID36061801
PMCPMC9434332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.